ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATBPF Antibe Therapeutics Inc (PK)

0.2156
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Antibe Therapeutics Inc (PK) USOTC:ATBPF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.2156 0.2156 0.2156 0.00 01:00:00

OTC Markets Group Welcomes Antibe Therapeutics to OTCQX®

15/09/2014 12:00pm

PR Newswire (US)


Antibe Therapeutics (PK) (USOTC:ATBPF)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Antibe Therapeutics (PK) Charts.

NEW YORK, Sept. 15, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Antibe Therapeutics Inc. (TSX-V: ATE; OTCQX: ATBPF), a human drug development company, has qualified to trade on OTCQX®, the best marketplace.

Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

Antibe begins trading today on OTCQX under the symbol "ATBPF."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"Antibe is developing improved versions of existing non-steroidal anti-inflammatory drugs, NSAIDs, a $12 billion global market with a key unmet need," said R. Cromwell Coulson, President and CEO of OTC Markets Group.  "We are pleased to welcome Antibe to our family of established, investor-focused companies on OTCQX and wish the company continued growth and success." 

Dr. Michael Bumby, Antibe's CFO said, "We view trading on OTCQX as an important step in our capital markets strategy as we continue to build our company and broaden our development portfolio."

Merriman Capital, Inc. serves as Antibe's Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements.

About Antibe Therapeutics Inc.
Antibe develops safer medicines for pain and inflammation.  Antibe's technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce a patented, improved medicine.  Antibe's ATB-346 targets the global need for a safer non-steroidal anti-inflammatory drug (NSAID).

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

SOURCE OTC Markets Group Inc.

Copyright 2014 PR Newswire

1 Year Antibe Therapeutics (PK) Chart

1 Year Antibe Therapeutics (PK) Chart

1 Month Antibe Therapeutics (PK) Chart

1 Month Antibe Therapeutics (PK) Chart

Your Recent History

Delayed Upgrade Clock